Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Roche
Roche
Roche's Purchase Of Genia A Long-Term Move
Seeking Alpha
Fri, 06/13/14 - 09:20 am
Roche
Genia Technologies
M&A
Italy's move to fund unapproved use of Roche's Avastin alarms the industry
Fierce Pharma
Wed, 06/11/14 - 10:47 am
Italy
Roche
Avastin
age-related macular degeneration
FirstWord List: Top 15 pharma and lead product dependency
First Word Pharma
Mon, 06/9/14 - 10:35 am
Teva
AbbVie
Boehringer Ingelheim
GSK
Sanofi
Amgen
Eli Lilly
JNJ
AstraZeneca
Roche
Novartis
Merck
Pfizer
Takeda
Bristol-Myers Squibb
This Week in Biotech: A Trifecta of Disappointment Mars ASCO While Biogen Scores a Big Victory
Motley Fool
Mon, 06/9/14 - 09:17 am
ASCO
Biogen Idec
Elocate
neratinib
Puma Biotechnology
CO-1686
Clovis Oncology
Tykerb
GSK
Roche
ASCO 2014: Doubling Down on Next-Gen Cancer Drugs
Motley Fool
Tue, 06/3/14 - 12:26 pm
ASCO
Roche
Amgen
blinatumomab
AstraZeneca
cancer
biospecific antibodies
Using Avastin for Eye Disorder Could Save U.S. $3 Billion
Bloomberg
Mon, 06/2/14 - 06:13 pm
Avastin
Roche
Lucentis
age-related macular degeneration
diabetic macular edema
Bristol Defends Data; Roche Shines In Cancer Showdown
Investors.com
Mon, 06/2/14 - 02:51 pm
Roche
Bristol-Myers Squibb
nivolumab
Yervoy
melanoma
MPDL3280A
bladder cancer
ASCO
Roche Agrees to Buy Genia Technologies for Up to $350 Million
Bloomberg
Mon, 06/2/14 - 11:02 am
Roche
Genia Technologies
M&A
gene sequencing
Cancer Conference Winners And Losers
Forbes
Mon, 06/2/14 - 10:38 am
ASCO
GSK
Puma Biotechnology
Merck
Roche
Bristol-Myers Squibb
Kite
Novartis
Juno Therapeutics
Eli Lilly
Clovis Oncology
AstraZeneca
Roche returns to antibiotic research as superbug threat grows
Yahoo/Reuters
Mon, 06/2/14 - 10:33 am
Roche
antibiotics
superbugs
R&D
Investigational immunotherapy anti-PDL1 (MPDL3280A) shrank tumours in 43 percent of people with a specific type of metastatic bladder cancer in a Roche study
Pipeline Review
Sun, 06/1/14 - 11:48 am
MPDL3280A
Roche
bladder cancer
Italy to seek $1.6 billion damages from Roche, Novartis
Marketwatch
Thu, 05/29/14 - 01:14 pm
Italy
Roche
Novartis
antitrust
Lucentis
Immune Therapy’s Cancer Promise Creates Research Rush
Bloomberg
Thu, 05/29/14 - 08:52 am
cancer immunotherapy
Merck
MK-3475
Roche
Yervoy
Bristol-Myers Squibb
Merck KGaA
AstraZeneca
3 Breakthrough Drugs Yield 1 Instant Blockbuster
Motley Fool
Sun, 05/25/14 - 10:26 am
Roche
Gazyva
Imbruvica
JNJ
Gilead Sciences
Sovaldi
mantle cell lymphoma
chronic lymphocytic leukemia
leukemia
Biogen
hepatitis
hepatitus C
Roche Says Authorities Visited Office in China’s Hangzhou
Bloomberg
Thu, 05/22/14 - 08:42 am
China
Roche
Roche Immune Therapy Drug Helps Bladder Cancer Patients
Bloomberg
Thu, 05/15/14 - 11:00 am
Roche
bladder cancer
MPDL3280A
Bristol, Merck, Roche immune therapies are cancer meeting focus
Yahoo/Reuters
Thu, 05/15/14 - 08:24 am
Bristol-Myers Squibb
Merck
Roche
ASCO
cancer
anti-PD-1 immunotherapy
Cancer drugs from J&J, Roche, Celgene and more rival last big oncology wave
Fierce Pharma Marketing
Thu, 05/8/14 - 12:30 pm
oncology
JNJ
Roche
Celgene
Zytiga
Kadcyla
Nexavar
Gleevec
Why Merck Is Still A Big Pharma Kingpin
Seeking Alpha
Mon, 05/5/14 - 08:26 am
Merck
Bristol-Myers Squibb
Gilead Sciences
Roche
MK-3475
hepatitis C
New Melanoma Therapies Are Ready For Primetime: Sanjiv Agarwala
Seeking Alpha
Wed, 04/30/14 - 12:50 pm
melanoma
Bristol-Myers Squibb
Roche
Merck
Amgen
Pages
« first
‹ previous
…
65
66
67
68
69
70
71
72
73
…
next ›
last »